The board of State Bank of India on Wednesday approved a proposal to raise upto Rs 11,100 crore through perpetual debt. Anshula Kant, Deputy Managing Director and Chief Financial Officer at SBI said that the bank has been working on different ways to raise capital. The bank has strong capital adequacy at the moment and won't require any capital in the year, she told CNBC-TV18, adding that the decision on timeframe of the debt-raising will depend on market appetite. Commenting on the development, Siddharth Purohit of Angel Broking said that SBI is gearing for capital raising and when loan growth picks ups it'll need tier 1 and tier 2 capital. this will help the bank meet additional capital merger. This is an indication that the management is gearing for incremental loan growth in coming quarters, he said. He said he expects the bank to clock a 12-13 percent standalone growth in FY17, but FY18 will be better. SBI on Wednesday informed the BSE that "the Committee of Directors for Capital Raising at its meeting held on August 24, 2016 authorised the bank to raise up to Rs 11,100 crore additional tier 1 capital, by way of issue of Basel III compliant perpetual debt instrument in USD and/or INR, at par, through private placement to overseas and/or Indian investors".
Wednesday, 24 August 2016
Home »
» SBI to raise up to Rs 11,100 cr via perpetual debt-:- Equity Research
SBI to raise up to Rs 11,100 cr via perpetual debt-:- Equity Research
04:35
Related Posts:
US FDA had inspected Lupin's Dabhasa unit this month -:- Equity Research Pharma major Lupin today said that the Unites States Food & Drug Association (US FDA) inspected its Dabhasa facility between June 29 and July 6. Post the inspection, Form FDA 483 observations were issued by t… Read More
Pokemon game adds $7.5 bn to Nintendo market value in two -:- Equity Research Shares in Japan's Nintendo Co Ltd soared again on Monday, bringing market-value gains to USD7.5 billion in just two days as investors cheered the runaway success of Pokemon GO - its first long-awaited venture in mobile … Read More
Sadbhav Engg sees cost of funds going down by Rs 70 cr in FY17 -:- Equity Research Speaking to CNBC-TV18 Nitin Patel of Sadbhav Engineering said that growth in tolling revenue and traffic are key triggers for the company. The company has completed refinancing 5 special purporse vehicles (SPVs) … Read More
llout of InfuSMART to begin with UK, Netherlands-:- Equity Research India's largest drug maker Sun Pharma began the rollout of its anti-cancer product ‘Gemcitabine InfuSMART’, a ready-to-administer bag for oncology treatment in six European countries. Talking about the above deve… Read More
India an outperformer among emerging markets -:- Equity Research Speaking to CNBC-TV18 Tim Condon of ING Financial Markets said that the US non-farm payroll data might come in at about 170,000. He also added that anything less than the 180,000 will be considered negative by the marke… Read More
0 comments:
Post a Comment